12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Cell Therapeutics sales and marketing update

Cell Therapeutics launched Pixuvri pixantrone in Sweden, Denmark and Finland to treat patients with multiply relapsed or refractory aggressive non-Hodgkin's B cell lymphoma. The company said launches in Austria and Norway are expected next month, with launches in Germany, the U.K. and the Netherlands planned for November....

Read the full 221 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >